Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.

<h4>Objective</h4>To screen and characterize germline variants for E-cadherin (CDH1) in non-hereditary gastric cancer (GC) patients and in subjects at risk of GC.<h4>Methods</h4>59 GCs, 59 first degree relatives (FDRs) of GC, 20 autoimmune metaplastic atrophic gastritis (AMAG...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marica Garziera, Vincenzo Canzonieri, Renato Cannizzaro, Silvano Geremia, Laura Caggiari, Mariangela De Zorzi, Stefania Maiero, Enrico Orzes, Tiziana Perin, Stefania Zanussi, Paolo De Paoli, Valli De Re
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/00be5c83978740a68758cc14f936e463
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:00be5c83978740a68758cc14f936e463
record_format dspace
spelling oai:doaj.org-article:00be5c83978740a68758cc14f936e4632021-11-18T08:49:12ZIdentification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.1932-620310.1371/journal.pone.0077035https://doaj.org/article/00be5c83978740a68758cc14f936e4632013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24204729/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objective</h4>To screen and characterize germline variants for E-cadherin (CDH1) in non-hereditary gastric cancer (GC) patients and in subjects at risk of GC.<h4>Methods</h4>59 GCs, 59 first degree relatives (FDRs) of GC, 20 autoimmune metaplastic atrophic gastritis (AMAGs) and 52 blood donors (BDs) were analyzed for CDH1 by direct sequencing, structural modelling and bioinformatics. Functional impact on splicing was assessed for intronic mutations. E-cadherin/β-catenin immunohistochemical staining and E-cadherin mRNA quantification using RT-PCR were performed.<h4>Results</h4>In GCs, 4 missense variants (p.G274S; p.A298T; p.T470I; p.A592T), 1 mutation in the 5'UTR (-71C>G) and 1 mutation in the intronic IVS12 (c.1937-13T>C) region were found. First pathogenic effect of p.A298T mutation was predicted by protein 3D modelling. The novel p.G274S mutation showed a no clear functional significance. Moreover, first, intronic IVS12 (c.1937-13T>C) mutation was demonstrated to lead to an aberrant CDH1 transcript with exon 11 deletion. This mutation was found in 2 GCs and in 1 BD. In FDRs, we identified 4 variants: the polymorphic (p.A592T) and 3 mutations in untranslated regions with unidentified functional role except for the 5'UTR (-54G>C) that had been found to decrease CDH1 transcription. In AMAGs, we detected 2 alterations: 1 missense (p.A592T) and 1 novel variant (IVS1 (c.48+7C>T)) without effect on CDH1 splicing. Several silent and polymorphic substitutions were found in all the groups studied.<h4>Conclusions</h4>Overall our study improves upon the current characterization of CDH1 mutations and their functional role in GC and in individuals at risk of GC. Mutations found in untranslated regions and data on splicing effects deserve a particular attention like associated with a reduced E-cadherin amount. The utility of CDH1 screening, in addition to the identification of other risk factors, could be useful for the early detection of GC in subjects at risk (i.e. FDRs and AMAGs), and warrants further study.Marica GarzieraVincenzo CanzonieriRenato CannizzaroSilvano GeremiaLaura CaggiariMariangela De ZorziStefania MaieroEnrico OrzesTiziana PerinStefania ZanussiPaolo De PaoliValli De RePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 10, p e77035 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marica Garziera
Vincenzo Canzonieri
Renato Cannizzaro
Silvano Geremia
Laura Caggiari
Mariangela De Zorzi
Stefania Maiero
Enrico Orzes
Tiziana Perin
Stefania Zanussi
Paolo De Paoli
Valli De Re
Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
description <h4>Objective</h4>To screen and characterize germline variants for E-cadherin (CDH1) in non-hereditary gastric cancer (GC) patients and in subjects at risk of GC.<h4>Methods</h4>59 GCs, 59 first degree relatives (FDRs) of GC, 20 autoimmune metaplastic atrophic gastritis (AMAGs) and 52 blood donors (BDs) were analyzed for CDH1 by direct sequencing, structural modelling and bioinformatics. Functional impact on splicing was assessed for intronic mutations. E-cadherin/β-catenin immunohistochemical staining and E-cadherin mRNA quantification using RT-PCR were performed.<h4>Results</h4>In GCs, 4 missense variants (p.G274S; p.A298T; p.T470I; p.A592T), 1 mutation in the 5'UTR (-71C>G) and 1 mutation in the intronic IVS12 (c.1937-13T>C) region were found. First pathogenic effect of p.A298T mutation was predicted by protein 3D modelling. The novel p.G274S mutation showed a no clear functional significance. Moreover, first, intronic IVS12 (c.1937-13T>C) mutation was demonstrated to lead to an aberrant CDH1 transcript with exon 11 deletion. This mutation was found in 2 GCs and in 1 BD. In FDRs, we identified 4 variants: the polymorphic (p.A592T) and 3 mutations in untranslated regions with unidentified functional role except for the 5'UTR (-54G>C) that had been found to decrease CDH1 transcription. In AMAGs, we detected 2 alterations: 1 missense (p.A592T) and 1 novel variant (IVS1 (c.48+7C>T)) without effect on CDH1 splicing. Several silent and polymorphic substitutions were found in all the groups studied.<h4>Conclusions</h4>Overall our study improves upon the current characterization of CDH1 mutations and their functional role in GC and in individuals at risk of GC. Mutations found in untranslated regions and data on splicing effects deserve a particular attention like associated with a reduced E-cadherin amount. The utility of CDH1 screening, in addition to the identification of other risk factors, could be useful for the early detection of GC in subjects at risk (i.e. FDRs and AMAGs), and warrants further study.
format article
author Marica Garziera
Vincenzo Canzonieri
Renato Cannizzaro
Silvano Geremia
Laura Caggiari
Mariangela De Zorzi
Stefania Maiero
Enrico Orzes
Tiziana Perin
Stefania Zanussi
Paolo De Paoli
Valli De Re
author_facet Marica Garziera
Vincenzo Canzonieri
Renato Cannizzaro
Silvano Geremia
Laura Caggiari
Mariangela De Zorzi
Stefania Maiero
Enrico Orzes
Tiziana Perin
Stefania Zanussi
Paolo De Paoli
Valli De Re
author_sort Marica Garziera
title Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
title_short Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
title_full Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
title_fullStr Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
title_full_unstemmed Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
title_sort identification and characterization of cdh1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/00be5c83978740a68758cc14f936e463
work_keys_str_mv AT maricagarziera identificationandcharacterizationofcdh1germlinevariantsinsporadicgastriccancerpatientsandinindividualsatriskofgastriccancer
AT vincenzocanzonieri identificationandcharacterizationofcdh1germlinevariantsinsporadicgastriccancerpatientsandinindividualsatriskofgastriccancer
AT renatocannizzaro identificationandcharacterizationofcdh1germlinevariantsinsporadicgastriccancerpatientsandinindividualsatriskofgastriccancer
AT silvanogeremia identificationandcharacterizationofcdh1germlinevariantsinsporadicgastriccancerpatientsandinindividualsatriskofgastriccancer
AT lauracaggiari identificationandcharacterizationofcdh1germlinevariantsinsporadicgastriccancerpatientsandinindividualsatriskofgastriccancer
AT mariangeladezorzi identificationandcharacterizationofcdh1germlinevariantsinsporadicgastriccancerpatientsandinindividualsatriskofgastriccancer
AT stefaniamaiero identificationandcharacterizationofcdh1germlinevariantsinsporadicgastriccancerpatientsandinindividualsatriskofgastriccancer
AT enricoorzes identificationandcharacterizationofcdh1germlinevariantsinsporadicgastriccancerpatientsandinindividualsatriskofgastriccancer
AT tizianaperin identificationandcharacterizationofcdh1germlinevariantsinsporadicgastriccancerpatientsandinindividualsatriskofgastriccancer
AT stefaniazanussi identificationandcharacterizationofcdh1germlinevariantsinsporadicgastriccancerpatientsandinindividualsatriskofgastriccancer
AT paolodepaoli identificationandcharacterizationofcdh1germlinevariantsinsporadicgastriccancerpatientsandinindividualsatriskofgastriccancer
AT vallidere identificationandcharacterizationofcdh1germlinevariantsinsporadicgastriccancerpatientsandinindividualsatriskofgastriccancer
_version_ 1718421242496679936